Your browser doesn't support javascript.
loading
Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study.
Pagliari, Maria Teresa; Rosendaal, Frits R; Ahmadinejad, Minoo; Badiee, Zahra; Baghaipour, Mohammad-Reza; Baronciani, Luciano; Benítez Hidalgo, Olga; Bodó, Imre; Budde, Ulrich; Castaman, Giancarlo; Eshghi, Peyman; Goudemand, Jenny; Karimi, Mehran; Keikhaei, Bijan; Lassila, Riitta; Leebeek, Frank W G; Lopez Fernandez, Maria Fernanda; Mannucci, Pier Mannuccio; Marino, Renato; Oldenburg, Johannes; Peake, Ian; Santoro, Cristina; Schneppenheim, Reinhard; Tiede, Andreas; Toogeh, Gholamreza; Tosetto, Alberto; Trossaert, Marc; Yadegari, Hamideh; Zetterberg, Eva M K; Peyvandi, Flora; Federici, Augusto B; Eikenboom, Jeroen.
Affiliation
  • Pagliari MT; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
  • Rosendaal FR; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Ahmadinejad M; Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
  • Badiee Z; Pediatric Congenital Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Baghaipour MR; Hemophilia-Thalassemia Center, Mashhad University of Medical Science, Mashad, Iran.
  • Baronciani L; Iranian Hemophilia Comprehensive Treatment Centre, Tehran, Iran.
  • Benítez Hidalgo O; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.
  • Bodó I; Hemophilia Unit,Hematology Department, Hospital Universitari Vall d'Hebron, Spain.
  • Budde U; Department of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.
  • Castaman G; Hemostaseology Medilys Laborgesellschaft mbH, Hamburg, Germany.
  • Eshghi P; Center for Bleeding Disorders and Coagulation, Careggi University Hospital, Florence, Italy.
  • Goudemand J; Pediatric Congenital Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Karimi M; Department of Hematology and Transfusion, CHU Lille, University of Lille, Lille, France.
  • Keikhaei B; Hematology Research Center,Nemazee Hospital, Shiraz University of Medical Science, Shiraz, Iran.
  • Lassila R; Thalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Leebeek FWG; Research Program Unit in Oncology, University of Helsinki, Helsinki University Central Hospital, Coagulation Disorders, Helsinki, Finland.
  • Lopez Fernandez MF; Department of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Mannucci PM; Complejo Hospitalario Universitario de A Coruña-Servicio de Hematología y Hemoterapia, A Coruña, Spain.
  • Marino R; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.
  • Oldenburg J; Hemophilia and Thrombosis Centre, University Hospital Policlinico, Bari, Italy.
  • Peake I; Institute of Experimental Haematology and Transfusion Medicine, University of Bonn, Bonn, Germany.
  • Santoro C; Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, United Kingdom.
  • Schneppenheim R; Hematology, Hemophilia and Thrombosis Center, University Hospital Policlinico Umberto I, Rome, Italy.
  • Tiede A; Department of Pediatric Hematology and Oncology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Toogeh G; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Tosetto A; Thrombosis Hemostasis Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Trossaert M; Hemophilia and Thrombosis Center, Hematology Department, San Bortolo Hospital, Vicenza, Italy.
  • Yadegari H; Centre Régional de Traitement de l'Hémophilie-Laboratoire d'Hématologie, Nantes, France.
  • Zetterberg EMK; Institute of Experimental Haematology and Transfusion Medicine, University of Bonn, Bonn, Germany.
  • Peyvandi F; Skane University Hospital, Malmo, Sweden.
  • Federici AB; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.
  • Eikenboom J; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
J Thromb Haemost ; 20(5): 1106-1114, 2022 05.
Article in En | MEDLINE | ID: mdl-35092343
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Von Willebrand Diseases / Von Willebrand Disease, Type 3 Type of study: Diagnostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2022 Document type: Article Affiliation country: Italy
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Von Willebrand Diseases / Von Willebrand Disease, Type 3 Type of study: Diagnostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2022 Document type: Article Affiliation country: Italy